• Trials and Research

  Gilenya May Help Control Severe Respiratory Disease in COVID-19

  Posted by MS News Today Moderator on June 26, 2020 at 9:23 am

  

  A report details an RRMS patient on long-term Gilenya (fingolimod) use, who developed severe COVID-19 infection with lung involvement and recovered well. Read the full story here.

  What do you think of this news?

  MS News Today Moderator replied 5 years ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply